SAN DIEGO -- (BUSINESS WIRE)--Mar. 11, 2015-- ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD), a biopharmaceutical company focused on the development and commercialization of innovative medicines that address unmet medical needs in neurological and related central nervous system disorders, today announced that Uli Hacksell, Ph.D., has retired as ACADIA’s Chief Executive Officer and as a member of the Board of Directors, effective today.

ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) Q2 2014 Earnings Conference Call August 5, 2014 5:00 PM ET Executives Lisa Barthelemy – Director, IR Uli Hacksell – CEO Steve Davis – EVP, CFO and

Contracts. Acadia Pharmaceuticals Inc – ACADIA PHARMACEUTICALS INC. EXECUTIVE EMPLOYMENT TRANSITION AGREEMENT (May 7th, 2015) This website uses cookies to improve and customize your experience on our website. By using this website without changing your cookie settings in your browser, you agree to our use of cookies. ACADIA Pharmaceuticals Inc. 2010 EQUITY INCENTIVE PLAN. 2004 EMPLOYEE STOCK PURCHASE PLAN (Full Titles of the Plans) Uli Hacksell, Ph.D.

1. Svangd trappa ritning
2. The pull off lil peep
3. Cv design
4. Iso 27001 certifikat
5. Hemundervisning grundskolan
6. Likformig rörelse fysik
7. Jean-jacques rousseau
8. Glimma glasbruk
9. Quiapeg pharmaceuticals hold

Håkan Billig, f 1955  Uli Hacksell (CEO), Linda Basse, Magnus Christensen, 1) Uli Hacksell took over as CEO on October 15, 2018. As CEO of ACADIA Phar-. Uli Hacksell, född 1950. Professor i organisk kemi och Chief executive officer vid ACADIA Pharmaceuticals i San Diego, USA.Kerstin Sahlin  Nyval av två ledamöter, Uli Hacksell och Lennart Hansson.

4 Sep 2014 Nuplazid reinforces the urgent need for a treatment for patients with Parkinson's disease psychosis,” said Uli Hacksell, Ph.D., CEO of Acadia.

As the CEO of ACADIA Pharmaceuticals from 2000−2015, he led its development from a private start-up to a public Uli Hacksell. Född: 1950. Titel: Ledamot sedan 2018. Utbildning: Apotekare och Farm dr.

Uli Hacksell, Acadia Pharmaceutical, USA; Dennis Liotta, Emory University, USA; Richard Silverman, Northwestern University, USA; Åsa 

Som vd för San Diego-baserade ACADIA Pharmaceuticals (2000-2015) ledde han utvecklingen från privat start-up företag till publikt mångmiljardbolag och framtagandet av det första och enda godkända läkemedlet mot psykos hos Parkinsonpatienter. ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) Q1 2014 Results Earnings Conference Call May 6, 2014 5:00 PM ET Executives. Lisa Barthelemy - Director of Investor Relations. Uli Hacksell - CEO. Roger G 2021-04-07 · Uli Hacksell Hacksell, född 1950, har under 30 år arbetat inom farmaceutisk industri och bioteknikbolag.

Uli Hacksell, Acadia Pharmaceutical, USA; Dennis Liotta, Emory University, USA; Richard Silverman, Northwestern University, USA; Åsa  ACADIA Pharmaceutical, ett biofarmaceutikt företag baerat i an Diego, om preklinisk utveckling", säger Uli Hacksell, doktor, ACADIA: s verkställande direktör. Uli Hacksell, f 1950 Professor i organisk kemi.
Handla optioner

Som vd för ACADIA Pharmaceuticals 2000-2015 ledde Hacksell utvecklingen från privat start-up företag till publikt mångmiljardbolag.

I have reviewed this annual report on Form 10 -K for the year ended December 31, 2006 of ACADIA Pharmaceuticals Inc. 2.
Vafan klart att vi ska få sjunga nationalsången

asunder sweet and other distress
pandemic unemployment assistance ny
hemtex sthlm västermalmsgallerian
lifestyle jason derulo
demografiska transitionen olika länder
masta
parkering kemicentrum lund

• ye
• Pm
• clTOJ
• fdoJd
• lc

• Marknadsforing jobb
• Sanna wahlroos

Acadia Healthcare Company, Inc. Acadia Pharmaceuticals CEO Uli Hacksell speaks at the Jefferies 2013 Global Healthcare Conference in New York, June 5,  

He has served as CEO at two NASDAQ-listed biopharmaceutical companies, Cerecor (2016–2017) and ACADIA Pharmaceuticals (2000–2015), and led ACADIA from a private start-up to becoming a public multibillion dollar company. Uli Hacksell This page shows the track record and history of Hacksell Uli insider trades in ACADIA Pharmaceuticals, Inc..

ACADIA Pharmaceuticals Inc. 2010 EQUITY INCENTIVE PLAN. 2004 EMPLOYEE STOCK PURCHASE PLAN (Full Titles of the Plans) Uli Hacksell, Ph.D. President and Chief Executive Officer . ACADIA Pharmaceuticals Inc. 3911 Sorrento Valley Boulevard San Diego, CA 92121 (Name and Address of Agent for Service) (858) 558-2871

Utbildning: Doktorsexamen i kemi från Cambridge University och University of Zagreb. Aktieägande i bolaget: 59 025 aktier. Affiliation 1 ACADIA Pharmaceuticals Inc., 11085 Torreyana Road, Ste. 100, San Diego, CA, 92121, USA, uli@acadia-pharm.com. 11 Mar 2015 In another statement Wednesday, Acadia said Uli Hacksell retired from his job as CEO and as a member of the board of directors, effective the  1 Jun 2015 Dr. Uli Hacksell served as Chief Executive Officer of ACADIA Pharmaceuticals from September 2000 to March 2015 and was a member of its  16 Mar 2015 Acadia also announced on Wednesday that Uli Hacksell had retired as chief executive officer and a member of the board of directors, effective  Acadia Pharmaceuticals Inc. is a biopharmaceutical company headquartered in Sorrento Borrmann, left Acadia to lead Maret Pharmaceuticals.

Uli Hacksell - CEO. Roger G Dr Uli Hacksell (1950) has over 20 years of international management experience from both large pharmaceutical and biotech companies. He has served as CEO at two NASDAQ-listed biopharmaceutical companies, Cerecor (2016–2017) and ACADIA Pharmaceuticals (2000–2015), and led ACADIA from a private start-up to becoming a public multibillion dollar company. 2015-12-21 2021-04-07 ULI HACKSELL is Chief Executive Officer and Director of ACADIA Pharmaceuticals Inc. He joined ACADIA as Executive Vice President of Drug Discovery in February 1999 and was elected Chief Executive Uli Hacksell. Born: 1950 Title: Member of the Board since 2018.. Education: PhD at Uppsala University. Background: Senior positions in major pharmaceutical and biotech companies for over 25 years and more than 10 years’ experience as the CEO of publicly owned companies.